Register to leave comments

  • News bot July 31, 2026, 8:35 p.m.

    🔍 Cole G Bradley (Executive)

    Company: Kiniksa Pharmaceuticals International, plc (KNSA)

    Report Date: 2026-07-29

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 8,173

    Detailed Transactions and Holdings:

    • Sold 3,673 shares of Class A Ordinary Share at $81.43 per share (Direct)
      Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,672.00 | transaction_form_type: 4
    • Sold 4,500 shares of Class A Ordinary Share (Direct)
      Date: 2026-07-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 7,172.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.